Protocols

Before starting TB-500, the three things that matter most are: confirming the injury type is one with supporting preclinical data, using a conservative loading dose rather than starting at maintenance, and understanding that human trial evidence for musculoskeletal applications does not yet exist — outcomes are extrapolated from animal research.

Semax used for cognitive support is most effective at 300–600mcg intranasally, used on working days rather than daily. Overstimulation — reported as restlessness, disrupted sleep, or heightened anxiety — is almost always a dose or frequency issue, not an inherent property of the compound at therapeutic ranges.

The safest starting protocol for BPC-157 in 2026 is 250mcg subcutaneously once daily for 4 weeks, injected near the site of injury or discomfort. Starting low allows you to assess individual response before escalating. Most reported adverse effects occur at higher doses or with rapid escalation.